,,ii #aadth ,,congress #b;d ,session ,s4 #bgjj ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #ag1 #bjaf ,mr4 ,alexander 7for himself and ,mrs4 ,murray7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to update the authorizing provisions relating to the workforces of the ,national ,institutes of ,health and the ,food and ,drug ,administration1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,,fda and ,,nih ,workforce ,authorities ,modernization ,act4 #b4 ,silvio ,o4 ,conte senior biomedical research service 7a7 ,hiring and retention authority ,section #bbh of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bcg7 is amended-- 7#a7 in the section heading1 by inserting and ,biomedical ,product ,assessment after ,research2 7#b7 in subsection 7a7-- 7,a7 in paragraph 7#a71 by striking ,silvio ,o4 ,conte ,senior ,biomedical ,research ,service1 not to exceed #ejj members and inserting ,silvio ,o4 ,conte ,senior ,biomedical ,research and ,biomedical ,product ,assessment ,service 7in this section referred to as the ,service71 not to exceed #b1jjj members1 the purpose of which is to recruit and retain outstanding and qualified scientific and technical experts in the fields of biomedical research1 clinical research evaluation1 and biomedical product assessment2 7,b7 by amending paragraph 7#b7 to read as follows3 7#b7 ,the authority established in paragraph 7#a7 may not be construed to require the ,secretary to reduce the number of employees serving under any other employment system in order to offset the number of members serving in the ,service4 2 and 7,c7 by adding at the end the following3 7#c7 ,the ,secretary shall assign experts under this section to agencies within the ,department of ,health and ,human ,services taking into account the need for the expertise of such expert4 2 7#c7 in subsection 7b7-- 7,a7 in the matter preceding paragraph 7#a71 by striking or clinical research evaluation and inserting 1 clinical research evaluation1 or biomedical product assessment2 and 7,b7 in paragraph 7#a71 by inserting or a doctoral or master's level degree in engineering1 bioinformatics1 or a related or emerging field1 after the comma2 7#d7 in subsection 7d77#b71 by striking and shall not exceed the rate payable for level ,i of the ,executive ,schedule unless approved by the ,president under section #ecgg7;d77#b7 of title #e1 ,united ,states ,code and inserting and shall not exceed the amount of annual compensation 7excluding expenses7 specified in section #ajb of title #c1 ,united ,states ,code2 7#e7 by striking subsection 7e72 and 7#f7 by redesignating subsections 7f7 and 7g7 as subsections 7e7 and 7f71 respectively4 7b7 ,,gao study 7#a7 ,in general ,the ,comptroller ,general of the ,united ,states shall conduct a study of the effectiveness of the amendments to section #bbh of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bcg7 made by subsection 7a7 and the impact of such amendments1 if any1 on all agencies or departments of the ,department of ,health and ,human ,services1 and1 not later than #d years after the date of enactment of this ,act1 shall submit a report based on such study to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives4 7#b7 ,content of study and report ,the study and report under paragraph 7#a7 shall include an examination of the extent to which recruitment and retention of outstanding and qualified scientific1 medical1 or technical experts in the fields of biomedical research1 clinical research evaluation1 and biomedical product assessment has improved or otherwise has been affected by the amendments to section #bbh of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bcg7 made by subsection 7a71 including by determining1 during the period between the date of enactment of this ,act and the completion of the study-- 7,a7 the total number of members recruited and retained under the ,senior ,biomedical ,research and ,biomedical ,product ,assessment ,service under such section #bbh1 and the effect of increasing the number of members eligible for such ,service2 7,b7 the number of members of such ,senior ,biomedical ,research and ,biomedical ,product ,assessment ,service hired with a doctoral level degree in biomedicine or a related field1 or doctoral or master's level degree in engineering1 bioinformatics1 or a related or emerging field2 and 7,c7 how many ,senior ,biomedical ,research and ,biomedical ,product ,assessment ,service members have been hired by each agency or department of the ,department of ,health and ,human ,services1 and how such ,department assigns such members to each agency or department4 #c4 ,hiring authority for scientific1 technical1 and professional personnel 7a7 ,in general ,the ,federal ,food1 ,drug1 and ,cosmetic ,act is amended by inserting after section #gad 7#ba ,u4,s4,c4 #cgi;d-#c7 the following3 #gad;,a4 ,hiring authority for scientific1 technical1 and professional personnel 7a7 ,in general ,the ,secretary may1 without regard to the provisions of title #e1 ,united ,states ,code1 governing appointments in the competitive service1 appoint outstanding and qualified candidates to scientific1 technical1 or professional positions that support the development1 review1 and regulation of medical products4 ,such positions shall be within the competitive service4 7b7 ,compensation 7#a7 ,in general ,notwithstanding any other provision of law1 including any requirement with respect to ,general ,schedule pay rates under subchapter ,,iii of chapter #ec of title #e1 ,united ,states ,code1 and consistent with the requirements of paragraph 7#b71 the ,commissioner of ,food and ,drugs may determine and fix-- 7,a7 the annual rate of pay of any individual appointed under subsection 7a72 and 7,b7 for purposes of retaining qualified employees1 the annual rate of pay for any qualified scientific1 technical1 or professional personnel appointed to a position described in subsection 7a7 before the date of enactment of this section4 7#b7 ,limitation ,the annual rate of pay established pursuant to paragraph 7#a7 may not exceed the amount of annual compensation 7excluding expenses7 specified in section #ajb of title #c1 ,united ,states ,code4 7#c7 ,public availability ,the annual rate of pay provided to an individual in accordance with this section shall be publicly available information4 7c7 ,rule of construction ,the authorities under this section shall not be construed to affect the authority provided under section #gad4 7d7 ,report on workforce planning 7#a7 ,in general ,not later than #ah months after the date of enactment of the ,,fda and ,,nih ,workforce ,authorities ,modernization ,act1 the ,secretary shall submit a report on workforce planning to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives that examines the extent to which the ,food and ,drug ,administration has a critical need for qualified individuals for scientific1 technical1 or professional positions1 including-- 7,a7 an analysis of the workforce needs at the ,food and ,drug ,administration and the ,secretary's strategic plan for addressing such needs1 including through use of the authority under this section2 and 7,b7 a recruitment and retention plan for hiring qualified scientific1 technical1 and professional candidates1 which may include the use of-- 7i7 recruitment through non-governmental recruitment or placement agencies2 7ii7 recruitment through academic institutions2 7iii7 recruitment or hiring bonuses1 if applicable2 7iv7 recruitment using targeted direct hiring authorities2 and 7v7 retention of qualified scientific1 technical1 and professional employees using the authority under this section1 or other applicable authorities of the ,secretary4 7#b7 ,recommendations ,the report under paragraph 7#a7 may include the recommendations of the ,commissioner of ,food and ,drugs that would help the ,food and ,drug ,administration to better recruit and retain qualified individuals for scientific1 technical1 or professional positions at the agency4 4 7b7 ,,gao study and report 7#a7 ,in general ,the ,comptroller ,general of the ,united ,states shall conduct a study of the ability of the ,food and ,drug ,administration to hire1 train1 and retain qualified scientific1 technical1 and professional staff1 not including contractors1 necessary to fulfill the mission of the ,food and ,drug ,administration to protect and promote public health4 ,not later than ,january #a1 #bjbb1 the ,comptroller ,general shall submit a report on such study to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives4 7#b7 ,contents of study ,the ,comptroller ,general shall include in the study and report under paragraph 7#a7-- 7,a7 information about the progress of the ,food and ,drug ,administration in recruiting and retaining qualified scientific1 technical1 and professional staff outstanding in the field of biomedical research1 clinical research evaluation1 and biomedical product assessment2 7,b7 the extent to which critical staffing needs exist at the ,food and ,drug ,administration1 and barriers to hiring1 training1 and retaining qualified staff1 if any2 7,c7 an examination of the recruitment and retention strategies of the ,food and ,drug ,administration1 including examining any strategic workforce plan1 focused on improving scientific1 technical1 and professional staff recruitment and retention2 and 7,d7 recommendations for potential improvements that would address staffing needs of the ,food and ,drug ,administration4 #d4 ,establishment of food and drug administration intercenter institutes 7a7 ,in general ,chapter ,x of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cia et seq47 is amended by adding at the end the following3 #ajad4 ,food and ,drug ,administration ,intercenter ,institutes 7a7 ,in general ,the ,secretary shall establish one or more ,intercenter ,institutes within the ,food and ,drug ,administration 7referred to in this section as an ,institute7 for a major disease area or areas4 ,with respect to the major disease area of focus of an ,institute1 such ,institute shall develop and implement processes for coordination of activities1 as applicable to such major disease area or areas1 between the ,center for ,drug ,evaluation and ,research1 the ,center for ,biologics ,evaluation and ,research1 and the ,center for ,devices and ,radiological ,health 7for the purposes of this section1 referred to as the ,centers74 ,such activities may include-- 7#a7 coordination of staff from the ,centers with diverse product expertise in the diagnosis1 cure1 mitigation1 treatment1 or prevention of the specific diseases relevant to the major disease area of focus of the ,institute2 7#b7 streamlining1 where appropriate1 the review of medical products to diagnose1 cure1 mitigate1 treat1 or prevent the major disease area of focus of the ,institute1 applying relevant standards under sections #eje1 #eaj7k71 and #eae of this ,act and section #cea of the ,public ,health ,service ,act1 and other applicable authorities2 7#c7 promotion of scientific programs within the ,centers related to the major disease area of focus of the ,institute2 7#d7 development of programs and enhancement of strategies to recruit1 train1 and provide continuing education opportunities for the personnel of the ,centers with expertise related to the major disease area of focus of the ,institute2 7#e7 enhancement of the interactions of the ,centers with patients1 sponsors1 and the external biomedical community regarding the major disease area of focus of the ,institute2 and 7#f7 facilitation of the collaborative relationships of the ,centers with other agencies within the ,department of ,health and ,human ,services regarding the major disease area of focus of the ,institute4 7b7 ,implementation plan ,prior to establishing an ,institute under subsection 7a71 and not later than #a year after the date of enactment of the ,,fda and ,,nih ,workforce ,authorities ,modernization ,act1 the ,secretary shall publish a draft implementation plan for such ,institute1 and provide for not less than #fj calendar days for public comment on such plan4 7c7 ,timing ,the ,secretary shall establish at least one ,institute under subsection 7a7 within #a year of the closing of the public comment period under subsection 7b71 unless the ,secretary determines that establishing such ,institute would not be feasible or would not benefit the public health1 and publishes such determination on the public ,internet website of the ,food and ,drug ,administration4 7d7 ,termination of institutes ,the ,secretary may terminate any ,institute established pursuant to this section if the ,secretary determines such ,institute is no longer benefitting the public health4 ,not less than #fj days prior to so terminating an ,institute1 the ,secretary shall provide public notice1 including the rationale for such termination4 4 7b7 ,technical amendments ,chapter ,x of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cia et seq47 is amended-- 7#a7 by redesignating section #ajab as section #ajac2 and 7#b7 by redesignating the second section #ajaa 7with respect to improving the training of ,state1 local1 territorial1 and tribal food safety officials71 as added by section #bji7;a7 of the ,,fda ,food ,safety ,modernization ,act 7,public ,law #aaa-cec71 as section #ajab4 #e4 ,scientific meetings 7a7 ,in general ,scientific meetings that are attended by scientific or medical personnel1 or other professionals1 of the ,department of ,health and ,human ,services for whom attendance at such meeting is directly related to their professional duties and the mission of the ,department-- 7#a7 shall not be considered conferences for the purposes of complying with ,federal reporting requirements contained in annual appropriations ,acts or in this section2 and 7#b7 shall not be considered conferences for purposes of a restriction contained in an annual appropriations ,act1 based on ,office of ,management and ,budget ,memorandum ,m-#ab-ab or any other regulation restricting such travel4 7b7 ,limitation ,nothing in this section shall be construed to exempt travel for scientific meetings from ,federal regulations relating to travel4 7c7 ,reports ,each operating division of the ,department of ,health and ,human ,services shall prepare1 and post on an ,internet website of the operating division1 an annual report on scientific meeting attendance and related travel spending for each fiscal year4 ,such report shall include-- 7#a7 general information concerning the scientific meeting activities involved2 7#b7 information concerning the total amount expended for such meetings2 7#c7 a description of all such meetings that were attended by scientific or medical personnel1 or other professionals1 of each such operating division where the total amount expended by the operating division associated with each such meeting are in excess of #cj1jjj1 including-- 7,a7 the total amount of meeting expenses incurred by the operating division for such meeting2 7,b7 the location of such meeting2 7,c7 the date of such meeting2 7,d7 a brief explanation on how such meeting advanced the mission of the operating division2 and 7,e7 the total number of individuals whose travel expenses or other scientific meeting expenses were paid by the operating division2 and 7#d7 with respect to any such meeting where the total expenses to the operating division exceeded #aej1jjj1 a description of the exceptional circumstances that necessitated the expenditure of such amounts4 #f4 ,reagan-,udall ,foundation for the ,food and ,drug ,administration 7a7 ,board of ,directors 7#a7 ,composition and size ,section #ggj7;d77#a77;,c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;dd7d77#a77;,c77 is amended-- 7,a7 by redesignating clause 7ii7 as clause 7iii72 7,b7 by inserting after clause 7i7 the following3 7ii7 ,additional members ,the ,board1 through amendments to the bylaws of the ,foundation1 may provide that the number of voting members of the ,board shall be a number 7to be specified in such amendment7 greater than #ad4 ,any ,board positions that are established by any such amendment shall be appointed 7by majority vote7 by the individuals who1 as of the date of such amendment1 are voting members of the ,board and persons so appointed may represent any of the categories specified in subclauses 7,i7 through 7,v7 of clause 7i71 so long as no more than #cj percent of the total voting members of the ,board 7including members whose positions are established by such amendment7 are representatives of the general pharmaceutical1 device1 food1 cosmetic1 and biotechnology industries4 2 and 7,c7 in clause 7iii77,i71 as redesignated by subparagraph 7,a71 by striking ,the ex officio members shall ensure and inserting ,the ex officio members1 acting pursuant to clause 7i71 and the ,board1 acting pursuant to clause 7ii71 shall ensure4 7#b7 ,federal employees allowed to serve on ,board ,clause 7iii77,,ii7 of section #ggj7;d77#a77;,c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;dd7d77#a77;,c771 as redesignated by paragraph 7#a77;,a71 is amended by adding at the end the following3 ,for purposes of this section1 the term employee of the ,federal ,government does not include a special ,government employee1 as that term is defined in section #bjb7;a7 of title #ah1 ,united ,states ,code44 7#c7 ,staggered terms ,subparagraph 7,a7 of section #ggj7;d77#c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;dd7d77#c77 is amended to read as follows3 7,a7 ,term ,the term of office of each member of the ,board appointed under paragraph 7#a77;,c77i71 and the term of office of any member of the ,board whose position is established pursuant to paragraph 7#a77;,c77ii71 shall be #d years1 except that-- 7i7 the terms of offices for the members of the ,board initially appointed under paragraph 7#a77;,c77i7 shall expire on a staggered basis as determined by the ex officio members2 and 7ii7 the terms of office for the persons initially appointed to positions established pursuant to paragraph 7#a77;,c77ii7 may be made to expire on a staggered basis1 as determined by the individuals who1 as of the date of the amendment establishing such positions1 are members of the ,board4 4 7b7 ,executive ,director compensation ,section #ggj7;g77#b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;dd7g77#b77 is amended by striking but shall not be greater than the compensation of the ,commissioner4 7c7 ,separation of ,funds ,section #ggj7m7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;dd7m77 is amended by striking are held in separate accounts from funds received from entities under subsection 7i7 and inserting are managed as individual programmatic funds under subsection 7i71 according to best accounting practices4 #g4 ,,nih research information collection exempted from ,paperwork ,reduction ,act ,section #cja of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bda7 is amended by adding to the end the following3 7f7 ,paperwork reduction ,subchapter ,i of chapter #ce of title #dd1 ,united ,states ,code1 shall not apply to the collection of information during the conduct of research by the ,national ,institutes of ,health4 4 #h4 ,studies ,the ,federal ,food1 ,drug1 and ,cosmetic ,act is amended-- 7#a7 in section #eje7k77#e7 7#ba ,u4,s4,c4 #cee7k77#e77-- 7,a7 in subparagraph 7,a71 by inserting and after the semicolon2 7,b7 by striking subparagraph 7,b72 and 7,c7 by redesignating subparagraph 7,c7 as subparagraph 7,b72 7#b7 in section #eje;,a 7#ba ,u4,s4,c4 #cee;a71 by striking subsection 7p72 7#c7 in section #eje;,b 7#ba ,u4,s4,c4 #cee;c7-- 7,a7 by striking subsection 7l72 and 7,b7 by redesignating subsection 7m7 as subsection 7l72 and 7#d7 in section #ebc 7#ba ,u4,s4,c4 #cfjm71 by striking subsection 7d74